PRESENTED BY

NAUROZ KHAN (358)

INTRODUCTION
Abbott Laboratories
CLASS : BBA 8TH

SUBJECT

Investment Analysis And Portfolio Mgt
TEACHER Sir.Mansoor Ahmad

History
‡ Abbott Laboratories (NYSE: ABT) is a pharmaceutical health care company. ‡ It has 72,000 employees and operates in over 130 countries. ‡ The company headquarters are in Abbott Park, North Chicago, Illinois. ‡ The company was founded by Chicago physician, Dr. Wallace Calvin Abbott in 1888. ‡ In 1985, the company developed the first HIV blood screening test. ‡ In 2008, Abbott had over $29 billion in revenue.

Business
‡ Abbott's core businesses focus on pharmaceuticals, medical devices and nutritional products, which have been supplemented through several notable acquisitions. The firm currently divides itself into several divisions: ‡ Animal Health: Anesthesia for animals, Clinicare liquid animal diets and other veterinary products. ‡ Diabetes Care: Glucose monitoring device and medicine.

Business Cont«
‡ Diagnostics: Hematology, immunodiagnostic, oncology and clinical chemistry (including the i-Stat). ‡ Molecular: analysis of DNA, RNA, and proteins at the molecular level. ‡ Nutrition: Baby Nutrition (Similac, Isomil, and Gain), adult health products (Ensure and ZonePerfect) and special dietary needs (Glucerna). ‡ Vascular: Stents, vessel closure devices, endovascular and coronary technologies.

Theme
‡ 2010 has been a year of celebration for Abbott Pakistan as we achieved our vision of Rs 10 billion sales. ‡ We managed through several significant challenges, and exceeded our strategic and financial goals. ‡ Our Annual Report 2010's concept focuses on Celebration of our achievements in 2010. Achieving is one of our core values means Customer- focused outcomes and world-class execution.

Mission
‡ We drive for meaningful results -demanding of ourselves and each other because our work impacts people's lives. To deliver consistently superior products and services which contribute significantly to improve the quality of life of the consumers.

Vision

‡ To be a premier healthcare company in Pakistan.

Promise

‡ The promise of our company is in the promise that our work holds for health and life.

Senior Management Team
Asif Jooma (Chief Executive Officer) Syed Anis Ahmed (Chief Financial Officer) Sadi Syed (Operations Director) Dr. Sarmad Maqbool (Marketing & Strategy Director) ‡ Dr. Farrukh Hafeez (Quality Assurance Director) ‡ ‡ ‡ ‡

Key Competitors

Abbott Products

Our Core Values
‡ Pioneering: Leading-edge science and commercialization. ‡ Achieving: Customer-focused outcomes and worldclass execution. ‡ Caring: Making a difference in people¶s lives. ‡ Enduring: Commitment and purpose.

Our Strategic Priorities
‡ Innovating for the Future (R & D). ‡ Protecting Patients & Consumers (Ensuring quality). ‡ Safeguarding the Environment.

Social Responsibilities

‡ Human Resource Development. ‡ Environment, Health and Safety.

Market Share
‡ Abbott Pakistan achieved a market share of 6.1% as per IMS (Dec 2010, 12 Months) in the pharmaceutical and nutrition market (2009 market share: 5.8%).

Manufacturing
‡ Abbott Pakistan manufactures over 150 different pharmaceutical and general health care products for the local and export markets.

Business Process Improvement
‡ Abbott Pakistan has launched the RSO (Rationalization, Standardization, and Optimization) program through which packaging of various products is standardized to achieve operational efficiencies such as cost improvement, cycle time reduction, and better inventory management. ‡ The TPM (Total Productive Maintenance) program was launched to minimize breakdowns and reduce machine change over time to increase the productivity.

Key Financial Data
‡ Net sales for the thirteen months period registered an increase of 30% over last financial year (20% increases on 12 months comparable basis). ‡ Profit after tax for the thirteen months period was Rs 1,177 million (Financial Year 2009: Rs 609 million). Earnings per share for the thirteen months period were Rs 12.02 (Financial Year 2009: Rs 6.22 per share).

Contribution to National Exchequer
‡ Your Company has contributed Rs 1,507 million (2009: Rs 1,062 million) to the government and its agencies on account of various government levies including income tax, custom duties and sales tax etc.

Financial Analysis

Abbott LabXD $
Date Closing Rate

x

x- =U

U''

U''

std

1-Jan-09

85.13

2-Jan-09

89.38

4.25

0.049717

-0.04972

0.002472

2151.936

46.38896

3-Jan-09

93.84

4.46

0.049717

4.200283

17.64238

4-Jan-09

97

3.16

0.049717

4.410283

19.4506

Abbott LabXD %

Date

Closing Rate

X

X+1

product X+1

square root

square root -1

std

1-Jan-09

85.13

2-Jan-09

89.38

0.049923646

1.049923646

1.00051313

0.002017164 -0.997982836 -99.79828364

3-Jan-09

93.84

0.049899306

1.049899306

4-Jan-09

97

0.033674339

1.033674339

Sign up to vote on this title
UsefulNot useful